Search filters

List of works by Julie M Vose

18 F-fluorothymidine uptake in follicular lymphoma and error-prone DNA repair

scientific article published on 8 January 2014

2016 ASCO Presidential Address: "Collective Wisdom: The Future of Patient-Centered Care and Research".

scientific article published on 11 July 2016

A Phase I/II Multicenter, Open-Label Study of the Oral Histone Deacetylase Inhibitor Abexinostat in Relapsed/Refractory Lymphoma

scientific article

A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTR.

scientific article

A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma

scientific article

A multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era.

scientific article published on 27 January 2014

A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma

scientific article

A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy

scientific article

A phase I study of PRO131921, a novel anti-CD20 monoclonal antibody in patients with relapsed/refractory CD20+ indolent NHL: correlation between clinical responses and AUC pharmacokinetics

scientific article

A phase II multicenter study of troxacitabine in relapsed or refractory lymphoproliferative neoplasms or multiple myeloma

scientific article published on January 2007

A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): final results from the T- cell consortium trial

scientific article

A phase II study of the survivin suppressant YM155 in patients with refractory diffuse large B-cell lymphoma.

scientific article published on 17 October 2011

A prospective clinical trial evaluating the safety and efficacy of the combination of rituximab and plerixafor as a mobilization regimen for patients with lymphoma

scientific article published on 25 May 2012

A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival

scientific article published on 7 November 2002

ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project

scientific article

ATM, CTLA4, MNDA, and HEM1 in high versus low CD38 expressing B-cell chronic lymphocytic leukemia

scientific article

Activation of the STAT3 signaling pathway is associated with poor survival in diffuse large B-cell lymphoma treated with R-CHOP

scientific article

Active idiotypic vaccination versus control immunotherapy for follicular lymphoma

scientific article

Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma

scientific article published on 28 July 2008

Addressing Administrative and Regulatory Burden in Cancer Clinical Trials: Summary of a Stakeholder Survey and Workshop Hosted by the American Society of Clinical Oncology and the Association of American Cancer Institutes

scientific article

Adult Burkitt lymphoma: advances in diagnosis and treatment.

scientific article

Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets

scientific article

Advances in mobilization for the optimization of autologous stem cell transplantation

scientific article published on September 2009

Advances in the treatment of hematologic malignancies. Part 1 of a 3-part series: Aggressive lymphomas

scientific article published on April 2006

Aggressive lymphoma: improving treatment outcome with rituximab.

scientific article published in November 2002

Allogeneic transplants in follicular lymphoma: higher risk of disease progression after reduced-intensity compared to myeloablative conditioning

scientific article published on February 2008

An interview with Julie Vose: where is oncology heading?

scientific article published on 11 September 2015

Angioimmunoblastic T-cell lymphoma management

scientific article

Angioimmunoblastic T-cell lymphoma: the many-faced lymphoma

scientific article published on 23 January 2017

Appropriate Surveillance for Late Complications in Patients in Remission from Hodgkin Lymphoma ⬇️

scientific article published on September 1, 2012

Assessment of treatment-related myelodysplastic syndromes and acute myeloid leukemia in patients with non-Hodgkin lymphoma treated with tositumomab and iodine I131 tositumomab.

scientific article

Association of number of follow-up providers with outcomes in survivors of hematologic malignancies ⬇️

scientific article published on October 1, 2010

Atrazine and nitrate in public drinking water supplies and non-hodgkin lymphoma in nebraska, USA

scientific article

Autologous haematopoietic cell transplantation for non-Hodgkin lymphoma with secondary CNS involvement

scientific article published on 06 July 2013

Autologous transplantation for aggressive non-Hodgkin's lymphoma: results of a randomized trial evaluating graft source and minimal residual disease

scientific article published in May 2002

Autologous versus Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Patients with Chemosensitive Follicular Non-Hodgkin Lymphoma beyond First Complete Response or First Partial Response ⬇️

scientific article published on November 10, 2010

Autotransplantation for Mantle Cell Lymphoma ⬇️

scientific article published on September 1, 2012

BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma

scientific article published on 17 January 2006

BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximab

scientific article

BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma

scientific article

Bexxar: novel radioimmunotherapy for the treatment of low-grade and transformed low-grade non-Hodgkin's lymphoma

scientific article published on January 2004

Bortezomib Plus CHOP-Rituximab for Previously Untreated Diffuse Large B-Cell Lymphoma and Mantle Cell Lymphoma ⬇️

scientific article published on December 28, 2010

Brentuximab vedotin plus bendamustine: a highly active first salvage regimen for relapsed or refractory Hodgkin lymphoma

scientific article published on 27 April 2018

Building Bridges for Collective Wisdom

scientific article published on 23 September 2015

Bulky lymphadenopathy with poor clinical outcome is associated with ATM downregulation in B-cell chronic lymphocytic leukemia patients irrespective of 11q23 deletion

scientific article published in January 2007

B‐cell lymphoma, unclassifiable, with features intermediate between diffuse large B‐cell lymphoma and burkitt lymphoma: study of 39 cases ⬇️

scientific article published on April 18, 2013

CCL3 and CCL4 are biomarkers for B cell receptor pathway activation and prognostic serum markers in diffuse large B cell lymphoma

scientific article

CD43 expression is associated with inferior survival in the non-germinal centre B-cell subgroup of diffuse large B-cell lymphoma

scientific article published on 25 April 2013

CNOP for diffuse aggressive non-Hodgkin's lymphoma: the Nebraska lymphoma study group experience

scientific article published in April 2002

Cardiac magnetic resonance imaging for the assessment of the myocardium after doxorubicin-based chemotherapy

scientific article published in August 2015

Cell of origin fails to predict survival in patients with diffuse large B‐cell lymphoma treated with autologous hematopoietic stem cell transplantation ⬇️

scientific article published on October 18, 2011

Central Nervous System Complications and Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation.

scientific article published on 19 June 2015

Challenges in Opening and Enrolling Patients in Clinical Trials

scientific article published in January 2017

Chronic lymphocytic leukemia/small lymphocytic lymphoma, version 1.2015

scientific article published on March 2015

Circulating CD20 and CD52 in patients with non-Hodgkin's lymphoma or Hodgkin's disease

scientific article published on 01 December 2003

Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project

scientific article

Clinical relevance of circulating angiogenic factors in patients with non-Hodgkin's lymphoma or Hodgkin's lymphoma

scientific article

Clinical relevance of soluble HLA-I and beta2-microglobulin levels in non-Hodgkin's lymphoma and Hodgkin's disease

scientific article published on 20 March 2006

Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project

scientific article

Clinicopathologic features, management and outcomes of blastoid variant of mantle cell lymphoma: a Nebraska Lymphoma Study Group Experience.

scientific article published on 17 September 2015

Combination therapy for non-Hodgkin's lymphoma: an opportunity for pharmaceutical care in a specialty practice

scientific article published on 01 January 2002

Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma.

scientific article

Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?

scientific article

Current status of rituximab maintenance therapy

scientific article published on 01 December 2007

Dendritic cell-based therapy for mantle cell lymphoma.

scientific article published on June 2006

Diffuse Large B-Cell Lymphoma Version 1.2016

scientific article published on 01 February 2016

Diffuse Large B-Cell Lymphoma: Prospective Multicenter Comparison of Early Interim FLT PET/CT versus FDG PET/CT with IHP, EORTC, Deauville, and PERCIST Criteria for Early Therapeutic Monitoring

scientific article published on 08 February 2016

Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant Hodgkin lymphoma: a report of 21 cases from the Nebraska Lymphoma Study Group

scientific article published on 01 August 2004

Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant hodgkin lymphoma. A report of 21 cases from the Nebraska Lymphoma Study Group

scientific article published on 01 November 2003

Diffuse large B-cell lymphoma with concordant bone marrow involvement has peculiar genomic profile and poor clinical outcome.

scientific article

Disparity in survival outcome after hematopoietic stem cell transplantation for hematologic malignancies according to area of primary residence

scientific article

Does Functional Imaging Distinguish Nodular Lymphocyte-Predominant Hodgkin Lymphoma From T-Cell/Histiocyte-Rich Large B-Cell Lymphoma? ⬇️

scientific article published on June 15, 2013

Does a diffuse growth pattern predict for survival in patients with low-grade follicular lymphoma?

scientific article published in June 2009

Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantation

scientific article

Early-Stage Hodgkin Disease in a 24-Year-Old Woman ⬇️

scientific article published on 01 December 2011

Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation.

scientific article

Effect of linkage of transduction domain sequences to a lymphoma idiotype DNA vaccine on vaccine effectiveness

scientific article published on 01 October 2006

Efficacy, safety, pharmacokinetics and pharmacodynamics of SAR245409 (voxtalisib, XL765), an orally administered phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor: a phase 1 expansion cohort in patients with relapsed or refractory ly

scientific article published on 19 November 2014

Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project.

scientific article

Establishing an institutional model for the administration of tositumomab and iodine I 131 tositumomab

scientific article published on 01 April 2003

Estimating the State-Level Supply of Cancer Care Providers: Preparing to Meet Workforce Needs in the Wake of Health Care Reform

scientific article published on 12 November 2014

Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphoma

scientific article published on 01 October 2005

Follicular large cleaved cell (centrocytic) lymphoma: An unrecognized variant of follicular lymphoma

scientific article published on 20 November 2017

Follicular lymphoma in the United States: first report of the national LymphoCare study

scientific article published on 09 February 2009

Follicular lymphoma: expanding therapeutic options.

scientific article

Gains of MYC locus and outcome in patients with diffuse large B-cell lymphoma treated with R-CHOP

Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma

scientific article

Genetic Cancer Susceptibility Testing: Increased Technology, Increased Complexity

scientific article published on 31 August 2015

Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis

scientific article

Genomic lesions associated with a different clinical outcome in diffuse large B-Cell lymphoma treated with R-CHOP-21.

scientific article published on 31 August 2010

Genomic signatures in B-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?

scientific article published on 18 August 2015

Genomic signatures in T-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?

scientific article published on 18 August 2015

Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma

scientific article published on 10 December 2014

Graft-versus-host disease: how to translate new insights into new therapeutic strategies

scientific article

Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: characteristics, outcomes, and prognostication among a large multicenter cohort.

scientific article published on 4 June 2015

Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project

scientific article

Hedgehog-induced survival of B-cell chronic lymphocytic leukemia cells in a stromal cell microenvironment: a potential new therapeutic target

scientific article

Hematopoietic stem cell transplantation for Hodgkin's disease in a patient with dysfibrinogenemia and thrombosis

scientific article published on 01 April 2007

Hematopoietic stem cell transplantation for non-Hodgkin lymphoma.

scientific article published on 22 September 2014

High-Dose Therapy/Autologous Hematopoietic Stem Cell Transplantation in Relapsed or Refractory Marginal Zone Non-Hodgkin Lymphoma ⬇️

scientific article published on April 20, 2011

Hodgkin's disease in the elderly: improved treatment outcome with a doxorubicin-containing regimen

scientific article published in February 2002

Human immunodeficiency virus-associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapy.

scientific article published on 17 April 2012

IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma

scientific article

Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression Profiling

scientific article

Imaging in early-stage Hodgkin's lymphoma

scientific article published on 01 March 2010

Immune reconstitution after autologous hematopoietic transplantation with Lin-, CD34+, Thy-1lo selected or intact stem cell products

scientific article

Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab

scientific article

Impact of Conditioning Regimen on Outcome of 2-Year Disease-Free Survivors of Autologous Stem Cell Transplantation for Hodgkin Lymphoma ⬇️

scientific article published on June 15, 2013

Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis.

scientific article published on 26 August 2014

Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma

scientific article

Improving Outcomes for Patients With Diffuse Large B-Cell Lymphoma ⬇️

scientific article published on October 28, 2010

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs

scientific article published on 23 July 2015

Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR).

scientific article published on December 2008

Inhibition of 4EBP phosphorylation mediates the cytotoxic effect of mechanistic target of rapamycin kinase inhibitors in aggressive B-cell lymphomas

scientific article

Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia

scientific article

Integrated profiling of diffuse large B-cell lymphoma with 7q gain

scientific article published on 21 March 2011

Intensified chemotherapy for diffuse large B-cell lymphomas

scientific article published in November 2011

Interim results of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma

scientific article published on 11 December 2017

International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes

scientific article

Isolated MYC cytogenetic abnormalities in diffuse large B-cell lymphoma do not predict an adverse clinical outcome

scientific article published in April 2015

Julie M. Vose, MD, President of ASCO--and Editor-in-Chief of ONCOLOGY--Discusses Her New Role and the Importance of Investing Wisely in Cancer Research

scientific article published in September 2015

Late relapse in patients with diffuse large B‐cell lymphoma ⬇️

scientific article published on September 29, 2010

Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma

scientific article

Lenalidomide oral monotherapy produces a high response rate in patients with relapsed or refractory mantle cell lymphoma

scientific article

Lenalidomide oral monotherapy produces durable responses in relapsed or refractory indolent non-Hodgkin's Lymphoma

scientific article

Limited utility of routine surveillance imaging for classical Hodgkin lymphoma patients in first complete remission.

scientific article published on 7 April 2014

Long-term outcomes of autologous stem cell transplantation for follicular non-Hodgkin lymphoma: effect of histological grade and Follicular International Prognostic Index

scientific article published on 3 December 2007

Lymphodepleting effects and safety of pentostatin for nonmyeloablative allogeneic stem-cell transplantation1 ⬇️

scientific article published on September 15, 2003

Lymphoma 2006: classification and treatment

scientific article

Lymphoma diagnosis at an academic centre: rate of revision and impact on patient care

scientific article published on 04 April 2014

Lymphoma occurring during pregnancy: antenatal therapy, complications, and maternal survival in a multicenter analysis.

scientific article

MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximab

scientific article published on 08 February 2014

Management of extranodal natural killer/t-cell lymphoma, nasal type.

scientific article published on 03 January 2015

Management of indolent lymphoma: Where are we now and where are we going ⬇️

scientific article published on October 9, 2012

Mantle cell lymphoma: 2012 update on diagnosis, risk‐stratification, and clinical management ⬇️

scientific article published on June 1, 2012

Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management

scientific article published on December 2013

Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management

scientific article published on August 2015

Mantle cell lymphoma: 2017 update on diagnosis, risk-stratification, and clinical management

scientific article published on August 2017

Molecular diagnosis of Burkitt's lymphoma

scientific article published in June 2006

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma

scientific article

Molecular pathogenesis in non-Hodgkin lymphoma: implications for therapy

scientific article

Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study.

scientific article published on 15 July 2013

Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma

scientific article

Mortality patterns among recipients of autologous hematopoietic stem cell transplantation for lymphoma and myeloma in the past three decades.

scientific article published on 5 March 2015

Multiple myeloma. Clinical practice guidelines in oncology

scientific article published on 01 February 2007

Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma

scholarly article

Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry

scientific article published on 27 July 2004

Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study.

scientific article

NCCN Clinical Practice Guidelines in Oncology: non-Hodgkin's lymphomas

scientific article

NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia, Version 1.2017.

scientific article

NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3.2016.

scientific article

NCCN clinical practice guidelines in oncology: multiple myeloma

scientific article published on 01 October 2009

NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following All

scientific article published on 14 June 2010

NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on disease-specific methods and strategies for monitoring relapse following all

scientific article published on 15 July 2010

Non-Hodgkin lymphoma of the prostate

scientific article published on 02 September 2011

Non-Hodgkin's Lymphomas, version 3.2012

scientific article published on 01 December 2012

Non-Hodgkin's lymphoma. Clinical practice guidelines in oncology

scientific article published on 01 March 2006

Non-Hodgkin's lymphomas

scientific article published on 01 April 2008

Non-Hodgkin's lymphomas

scientific article published on 01 May 2011

Non-Hodgkin's lymphomas, version 1.2013.

scientific article

Non-Hodgkin's lymphomas, version 4.2014.

scientific article published on September 2014

Novel therapy for therapy-resistant mantle cell lymphoma: multipronged approach with targeting of hedgehog signaling.

scientific article

Novel treatment for mantle cell lymphoma including therapy-resistant tumor by NF-κB and mTOR dual-targeting approach.

scientific article published on 20 August 2013

Oligonucleotide microarrays demonstrate the highest frequency of ATM mutations in the mantle cell subtype of lymphoma ⬇️

scientific article published on April 15, 2003

Optimized adoptive T-cell therapy for the treatment of residual mantle cell lymphoma ⬇️

scientific article published on March 23, 2012

Optimizing the treatment of patients with rituximab-pretreated recurrent indolent non-Hodgkin lymphoma.

scientific article published on June 2008

Outcome of autologous transplantation for mantle cell lymphoma: a study by the European Blood and Bone Marrow Transplant and Autologous Blood and Marrow Transplant Registries

scientific article

Outcome of lower-intensity allogeneic transplantation in non-Hodgkin lymphoma after autologous transplantation failure.

scientific article

Outcomes after hematopoietic stem-cell transplantation for hematologic malignancies in patients with or without advance care planning

scientific article published on 01 December 2007

Outcomes of hematopoietic cell transplantation for diffuse large B cell lymphoma transformed from follicular lymphoma.

scientific article

Patients with chemotherapy-refractory mantle cell lymphoma experience high response rates and identical progression-free survivals compared with patients with relapsed disease following treatment with single agent bortezomib: results of a multicentr

scientific article

Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). A new prognostic model developed by the International T cell Project Network

scientific article published on 19 April 2018

Peripheral T-cell lymphoma

scientific article published on 14 April 2011

Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project

scientific article

Peripheral T-cell lymphoma: novel backbone

scientific article published in January 2018

Peripheral T-cell non-Hodgkin's lymphoma

scientific article

Personalized immunotherapy for the treatment of non-Hodgkin lymphoma: a promising approach

scientific article

Personalized immunotherapy for the treatment of non-Hodgkin's lymphoma: a promising approach

scientific article

Phase 1 trial of a novel anti-CD20 fusion protein in pretargeted radioimmunotherapy for B-cell non-Hodgkin lymphoma

scientific article published on 2 March 2004

Phase 1 trial of bortezomib plus R‐CHOP in previously untreated patients with aggressive non‐Hodgkin lymphoma ⬇️

scientific article published on July 27, 2010

Phase I trial of (90)Y-ibritumomab tiuxetan in patients with relapsed B-cell non-Hodgkin's lymphoma following high-dose chemotherapy and autologous stem cell transplantation

scientific article

Phase I trial of iodine-131 tositumomab with high-dose chemotherapy and autologous stem-cell transplantation for relapsed non-Hodgkin's lymphoma

scientific article published on 8 November 2004

Phase I/II study of bortezomib-BEAM and autologous hematopoietic stem cell transplantation for relapsed indolent non-Hodgkin lymphoma, transformed, or mantle cell lymphoma

scientific article published on 14 January 2014

Phase I/II study of galiximab, an anti-CD80 antibody, for relapsed or refractory follicular lymphoma

scientific article published on 01 July 2005

Phase II Trial of 131-Iodine Tositumomab with High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Relapsed Diffuse Large B Cell Lymphoma ⬇️

scientific article published on August 29, 2012

Phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory diffuse large B-cell lymphoma

scientific article

Phase III randomized study of rituximab/carmustine, etoposide, cytarabine, and melphalan (BEAM) compared with iodine-131 tositumomab/BEAM with autologous hematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: results from the

scientific article published on March 11, 2013

Pitfalls and major issues in the histologic diagnosis of peripheral T-cell lymphomas: results of the central review of 573 cases from the T-Cell Project, an international, cooperative study

scientific article published on 3 June 2016

Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival

scientific article published on 13 February 2007

Polo-Like Kinase 1: A Novel Target for the Treatment of Therapy-Resistant Mantle Cell Lymphoma

Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells

article

Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective stud

scientific article published on 23 September 2014

Prognostic factors in patients with HIV-associated peripheral T-cell lymphoma: a multicenter study

scientific article published on 15 February 2011

Prognostic factors influencing survival in patients with B-cell small lymphocytic lymphoma

scientific article

Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantation

scientific article published on 01 April 2005

Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project

scientific article

R-DHAP: a good small step, but not the journey's end.

scientific article published in June 2008

Rac1 is a novel therapeutic target in mantle cell lymphoma

scientific article published on 12 February 2018

Radioimmunotherapy for stem cell transplantation in non-Hodgkin's lymphoma: in pursuit of a complete response

scientific article published on January 2009

Radioimmunotherapy: a novel treatment modality for B-cell non-Hodgkin's lymphoma

scientific article published on 01 October 2003

Relapsed diffuse large B-cell lymphoma: clinical utility of cell of origin

scientific article published on 26 September 2011

Response assessment of aggressive non-Hodgkin's lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography

scientific article

Revised response criteria for malignant lymphoma

scientific article published on 22 January 2007

Risk of Second Primary Malignancies in Patients With Follicular Lymphoma: A United States Population-based Study

scientific article published on 24 June 2017

Rituximab Improves the Outcome of Patients With Grade 3 Follicular Lymphoma Receiving Anthracycline-Based Therapy

scientific article published on 16 June 2017

Role of cytotoxic therapy with hematopoietic cell transplantation in the treatment of Hodgkin lymphoma: guidelines from the American Society for Blood and Marrow Transplantation.

scientific article published on 12 March 2015

Role of radiation therapy in primary mediastinal large B-cell lymphoma in rituximab era: A US population-based analysis.

scientific article published on 13 August 2015

Salvage second hematopoietic cell transplantation in myeloma

scientific article

Sarcoidosis mimicking recurrent lymphoma ⬇️

scientific article published on December 27, 2011

Second autologous stem cell transplantation for relapsed lymphoma after a prior autologous transplant.

scientific article

Secondary acute myeloid leukemia in survivors of Hodgkin lymphoma

scientific article published on 15 April 2016

Senior adult oncology clinical practice guidelines in oncology

scientific article published on 01 July 2005

Single-agent lenalidomide is active in patients with relapsed or refractory aggressive non-Hodgkin lymphoma who received prior stem cell transplantation

scientific article published on 09 July 2013

Status of ongoing collaborative efforts

scientific article published on April 2010

Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study.

scientific article published on 17 June 2008

Survival disparities in patients with lymphoma according to place of residence and treatment provider: a population-based study

scientific article published on 14 September 2009

Survival of Subcutaneous Panniculitis-Like T-Cell Lymphoma and Peripheral T-Cell Lymphoma Not Otherwise Specified: A Propensity-Matched Analysis of the Surveillance, Epidemiology, and End Results Database

scientific article published on 4 May 2016

Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for

scientific article published on 08 September 2003

Targeting of sonic hedgehog-GLI signaling: a potential strategy to improve therapy for mantle cell lymphoma

scientific article

Ten Years of Progress in the Treatment of Non-Hodgkin’s Lymphoma ⬇️

scientific article published on 01 January 2013

The Plk1 inhibitor BI 2536 in patients with refractory or relapsed non-Hodgkin lymphoma: a phase I, open-label, single dose-escalation study

scientific article

The Stanford V regimen is effective in patients with good risk Hodgkin lymphoma but radiotherapy is a necessary component

scientific article published on 26 November 2008

The Stromal Cell Marker SPARC Predicts for Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab

article

The Value and Relevance of the T Cell Lymphoma Registries and International Collaborations: the Case of COMPLETE and the T-Cell Project

scientific article published on 08 October 2015

The addition of rituximab reduces the incidence of secondary central nervous system involvement in patients with diffuse large B-cell lymphoma

scientific article published on 09 January 2012

The combination of bendamustine, bortezomib, and rituximab for patients with relapsed/refractory indolent and mantle cell non-Hodgkin lymphoma

scientific article

The differential effect of lenalidomide monotherapy in patients with relapsed or refractory transformed non-Hodgkin lymphoma of distinct histological origin

scientific article published on 28 June 2011

The landscape of new drugs in lymphoma

scientific article published on 29 December 2016

The prognostic significance of lymphopenia in peripheral T-cell and natural killer/T-cell lymphomas: a study of 826 cases from the International Peripheral T-cell Lymphoma Project.

scientific article published on 10 April 2012

The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

article

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large B cell lymphoma: update of the 2001 evidence-based review

scientific article published on 23 July 2010

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large cell B-cell non-Hodgkin's lymphoma

scientific article published in October 2003

The role of hematopoietic stem cell transplant in follicular lymphoma

scientific article published on 01 March 2010

The role of hematopoietic stem cell transplantation in non-Hodgkin lymphoma.

scientific article published on July 2006

Time to treatment response in patients with follicular lymphoma treated with bortezomib is longer compared with other histologic subtypes

scientific article

To Surveil or Not to Surveil

scientific article published on 5 October 2015

Tositumomab and iodine-131 tositumomab produces durable complete remissions in a subset of heavily pretreated patients with low-grade and transformed non-Hodgkin's lymphomas

scientific article published on 26 September 2005

Tumor-specific recombinant idiotype immunisation after chemotherapy as initial treatment for follicular non-Hodgkin lymphoma

scientific article

Understanding evaluation and management of primary cutaneous and systemic ALCL

scientific article published on June 1, 2010

Unrelated donor hematopoietic cell transplantation for non-hodgkin lymphoma: long-term outcomes

scientific article

Unrelated donor reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma

scientific article

Update on epidemiology and therapeutics for non-Hodgkin's lymphoma

scientific article

Update on lymphoma management: diffuse large B-cell NHL.

scientific article

Urinary biomarkers suggest that estrogen-DNA adducts may play a role in the aetiology of non-Hodgkin lymphoma

scientific article

Utility of prechemotherapy evaluation of left ventricular function for patients with lymphoma

scientific article published on 25 June 2014

Venous thromboembolism in patients with hematologic malignancy and thrombocytopenia

scientific article

Paulina is supported by:

About Paulina

Help